D. L. Priel

发表

Glycosylation, hypogammaglobulinemia, and resistance to viral infections.

M. Hegde, T. Chun, J. Justement, 2014, The New England journal of medicine.

Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis.

S. Paul, D. Kuhns, D. McDermott, 2010, Blood.

Hematologically important mutations: The autosomal forms of chronic granulomatous disease (third update).

J. L. Shephard, M. Vihinen, H. Kanegane, 2021, Blood cells, molecules & diseases.

Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection.

S. Holland, E. Sampaio, Lindsey B. Rosen, 2012, Blood.

The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome.

T. Fleisher, D. Kuhns, D. McDermott, 2011, Blood.

Induction of Human Monocyte Interleukin (IL)-8 by Fibrinogen through the Toll-Like Receptor Pathway

D. Kuhns, J. Gallin, D. L. Priel, 2007, Inflammation.

Isolation and Functional Analysis of Human Neutrophils

D. Kuhns, K. Zarember, J. Chu, 2015, Current protocols in immunology.

Assessment of Atherosclerosis in Chronic Granulomatous Disease Imaging, Myocardial biology:[91] Oxidant stress

D. Bluemke, S. Holland, E. Turkbey, 2014 .

Assessment of Neutrophil Function

D. Kuhns, D. L. Priel, 2019, Clinical Immunology.

syndrome with the CXCR4 antagonist plerixafor A phase 1 clinical trial of long-term, low-dose treatment of WHIM

S. Pittaluga, D. Kuhns, D. McDermott, 2014 .

with WHIM syndrome The CXCR4 antagonist plerixafor corrects panleukopenia in patients

D. Kuhns, P. Murphy, R. Decastro, 2012 .

Generation of functionally mature neutrophils from induced pluripotent stem cells.

D. Kuhns, U. Choi, H. Malech, 2014, Methods in molecular biology.

Chromothriptic Cure of WHIM Syndrome

M. Raffeld, S. Pittaluga, Z. Dai, 2015, Cell.

A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor.

S. Pittaluga, T. Fleisher, D. Kuhns, 2014, Blood.

X‐linked carriers of chronic granulomatous disease: Illness, lyonization, and stability

S. Holland, S. Rosenzweig, D. Kuhns, 2018, The Journal of allergy and clinical immunology.

Residual NADPH oxidase and survival in chronic granulomatous disease.

S. Holland, W. Alvord, B. Soule, 2010, The New England journal of medicine.

Cytoskeletal abnormalities and neutrophil dysfunction in WDR1 deficiency.

Vanessa A Mackley, S. Lockett, J. Orange, 2016, Blood.

Distinct Cutaneous Manifestations and Cold-Induced Leukocyte Activation Associated With PLCG2 Mutations.

J. Lyons, J. Milner, D. Kuhns, 2015, JAMA dermatology.

PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS Cytoskeletal abnormalities and neutrophil dysfunction in WDR 1 de fi ciency

Vanessa A Mackley, S. Lockett, J. Orange, 2016 .

Hematologically important mutations: X-linked chronic granulomatous disease (fourth update).

J. L. Shephard, H. Kanegane, S. Holland, 2021, Blood cells, molecules & diseases.

An AAVS1-targeted minigene platform for correction of iPSCs from all five types of chronic granulomatous disease.

S. Holland, D. Kuhns, C. Dunbar, 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

B-cell activating factor (BAFF) is elevated in chronic granulomatous disease.

S. Holland, T. Fleisher, D. Kuhns, 2013, Clinical immunology.

Distinct CutaneousManifestations and Cold-Induced Leukocyte Activation AssociatedWith PLCG 2 Mutations

J. Lyons, J. Milner, D. Kuhns, 2015 .

NCF1 (p47phox)-deficient chronic granulomatous disease: comprehensive genetic and flow cytometric analysis.

S. Holland, A. Hsu, D. Kuhns, 2019, Blood advances.

NCF1 (p47 phox ) – de ﬁ cient chronic granulomatous disease: comprehensive genetic and ﬂ ow cytometric analysis

S. Holland, A. Hsu, D. Kuhns, 2019 .

Loss-of-function of the protein kinase C δ (PKCδ) causes a B-cell lymphoproliferative syndrome in humans.

J. B. Oliveira, S. Pittaluga, T. Fleisher, 2013, Blood.

Integrative DNA, RNA, and protein evidence connects TREML4 to coronary artery calcification.

Larry N. Singh, Andrew D. Johnson, J. Mullikin, 2014, American journal of human genetics.

Functional Assays for the Diagnosis of Chronic Granulomatous Disease

D. Kuhns, D. L. Priel, 2016 .

Endotoxin and IL-1 hyporesponsiveness in a patient with recurrent bacterial infections.

D. Kuhns, J. Gallin, D. L. Priel, 1997, Journal of immunology.

Glycosylation, hypogammaglobulinemia, and resistance to viral infections.

M. Hegde, T. Chun, J. Justement, 2014, The New England journal of medicine.

The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome.

T. Fleisher, D. Kuhns, H. Malech, 2011, Blood.

Characterization of the antispike IgG immune response to COVID-19 vaccines in people with a wide variety of immunodeficiencies

D. Kuhns, G. Uzel, C. Zerbe, 2023, Science advances.

Distinct Cutaneous Manifestations and Cold-Induced Leukocyte Activation Associated With PLCG2 Mutations.

J. Lyons, J. Milner, D. Kuhns, 2015, JAMA dermatology.